AST 202 - Aptamer Sciences
Alternative Names: AST 202 Aptamer drug conjugate; AST-202 - Aptamer Sciences; AST-202 ApDCLatest Information Update: 04 Dec 2023
Price :
$50 *
At a glance
- Originator Aptamer Sciences
- Class Antineoplastics; Drug conjugates; Oligonucleotides
- Mechanism of Action Interleukin-2 receptor alpha subunit antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Haematological malignancies; Solid tumours
Most Recent Events
- 01 Dec 2023 Early research in Haematological malignancies in South Korea (unspecified route) (Aptamer Sciences pipeline, December 2023)
- 01 Dec 2023 Early research in Solid tumours in South Korea (unspecified route) (Aptamer Sciences pipeline, December 2023)